SEC Filing Summary for Atea Pharmaceuticals, Inc. (AVIR)

This filing details transactions by Franklin M. Berger, a director at Atea Pharmaceuticals, Inc., on June 18, 2026. Berger acquired 37,700 stock options and 26,700 Restricted Stock Units (RSUs), with the options vesting over 12 months and RSUs vesting in full on the same day. Additionally, 29,600 RSUs were disposed of, and 29,600 shares of Common Stock were acquired. The RSUs represent contingent rights to receive one share of Common Stock upon vesting. The stock options have an exercise price of $4.36 and vest fully by June 18, 2027, subject to continued service. Post-transaction, Berger holds 536,097 shares of Common Stock.